Dr. Reddys Laboratories Ltd.

Dr Reddy’s is currently trading at Rs. 1760.00, up by 22.40 points or 1.29% from its previous closing of Rs. 1737.60 on the BSE.

The scrip opened at Rs. 1749.00 and has touched a high and low of Rs. 1765.00 and Rs. 1738.75 respectively. So far 3,875 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1968.60 on 25-Jan-2013 and a 52 week low of Rs. 1528.00 on 19-Jun-2012.

Last one week high and low of the scrip stood at Rs. 1813.00 and Rs. 1720.50 respectively. The current market cap of the company is Rs. 29,878 crore.

The promoters holding in the company stood at 25.56% while Institutions and Non-Institutions held 40.15% and 17.63% respectively.

Dr Reddys Laboratories has reported results for third quarter ended December 31, 2012.

The company has posted growth of over 3-fold in its net profit at Rs 346.64 crore for the quarter as compared to Rs 108.03 crore for the same quarter in the previous year. Total income from operation of the company has increased by 33.97% at Rs 2186.30 crore for quarter under review as compared to Rs 1631.86 crore for the quarter ended December 31, 2011.

The company, on consolidated basis, posted a fall of 29.17% in its net profit at Rs 363.31 crore for the quarter as compared to Rs 512.96 crore for the same quarter in the previous year. However, total income of the company increased by 3.69% at Rs 2888.47 crore for quarter under review as compared to Rs 2785.67 crore for the quarter ended December 31, 2011.